Welcome to our dedicated page for FIGS news (Ticker: $FIGS), a resource for investors and traders seeking the latest updates and insights on FIGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FIGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FIGS's position in the market.
FIGS, Inc. released its first quarter 2024 financial results showing net revenues hitting the upper end of expectations with adjusted EBITDA exceeding guidance. The company observed improved momentum in business, especially in repeat frequency trends. Despite a slight decrease in net revenues, the gross margin decreased primarily due to a product mix shift. Operating expenses were down year over year, leading to a decrease in net income and adjusted net income. Adjusted EBITDA also decreased, but active customers increased by 8.7%. The company is raising its full-year net revenues outlook while revising the adjusted EBITDA margin outlook. Financial highlights show a positive outlook for growth and strong free cash flow to support sustainable profitable growth.